PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression
暂无分享,去创建一个
S. Pinder | M. Simpson | E. Sawyer | A. Grigoriadis | T. Graham | D. Levi | R. Roylance | C. Gillett | V. Shah | S. Nowinski | I. Shinomiya | Narda Kebaier Ep Chaabouni